Gastrointestinal Drugs Market Analysis and Upcoming Trend by 2028 | Astrazeneca, Sanofi, Bayer, Pfizer, Glaxosmithkline, Teva 3
The Gastrointestinal Drugs report presents a high-quality, wide-ranging research study with key factors that are expected to have a major impact on Gastrointestinal Drugs over the forecast period. The report presents the key segments of the market measured by its growth rate and share.This report also provides an analysis of the impact of the COVID-19 pandemic on the industrial label industry.The report explains the historical and current trends that are shaping the growth of Gastrointestinal Drugs.
The Gastrointestinal Drugs market report provides an overview of several major countries spread across various geographic regions of the world. The report focuses on recognizing various market developments, dynamics, growth drivers and factors hindering market growth. In addition, the report provides comprehensive information on many growth opportunities and
Share this article
Share this article
ResearchAndMarkets.com s offering.
This report covers this critical market and the impact on it from the COVID-19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for gastrointestinal drugs. Vitamins and Minerals play a crucial role in the treatment of patients with COVID-19 as they are used as immunity boosters.
The global gastrointestinal drugs market is expected to grow from $46.68 billion in 2020 to $48.74 billion in 2021 at a compound annual growth rate (CAGR) of 4.4%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $62.19 billion in 2025 at a CAGR of 6%.
Global Gastrointestinal Drugs Market Report (2021 to 2030) - COVID-19 Implications and Growth
May 10, 2021 05:53 ET | Source: Research and Markets Research and Markets Dublin, IRELAND
ResearchAndMarkets.com s offering.
This report covers this critical market and the impact on it from the COVID-19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for gastrointestinal drugs. Vitamins and Minerals play a crucial role in the treatment of patients with COVID-19 as they are used as immunity boosters.
The global gastrointestinal drugs market is expected to grow from $46.68 billion in 2020 to $48.74 billion in 2021 at a compound annual growth rate (CAGR) of 4.4%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is ex